Molecular & Cellular Biotherapies

Molecular & Cellular Biotherapies (MCB)

The track on Biotherapies and Advanced Therapy Medicinal Products (ATMPs) offers an exciting opportunity to dive deep into some of the most revolutionary fields in modern medicine. The program is designed to provide students with a comprehensive knowledge of the rapidly evolving areas of cell- and gene-based therapies, tissue engineering and regenerative medicine. Through a blend of lectures, hands-on laboratory work, and case studies, the program is structured to address key aspects of biotherapy development, including molecular and cellular/stem cell biology, immunology, and bioengineering techniques, providing participants with a solid grasp of the science behind advanced therapies.

Additionally, the program explores the regulatory frameworks and the clinical applications essential for the development and safe administration of these innovative therapies, preparing them for research and career opportunities in academia as well as in biopharmaceutical and biotechnology firms, specialized in these fast-growing therapies.

The MCB track thus serves as a comprehensive pathway into the expanding fields of cell and gene therapy, biopharmaceuticals, and regenerative medicine positioning students at the forefront of groundbreaking therapeutic innovations.

Semester 3

Mandatory courses

Interdisciplinary Seminar (3 ECTS)
Research Methodology (3 ECTS)
Gene Transfer Strategies (3 ECTS)
Basic Immunology in Biotherapies (3 ECTS)
Stem Cells and Regenerative Medicine (3 ECTS)
Gene and Cell Therapies : Clinical Applications (9 ECTS)
Cancer Therapies/Immunotherapies (3 ECTS)
Tissue engineering (3 ECTS)

Semester 4 (30 ECTS)

Mandatory courses

Ethical, Industrial and Environmental aspects in biomedical engineering (3 ECTS)
Bioinformatics (3 ECTS)
Internship (24 ECTS)
800
graduate students since 2010
90
nationalities represented since 2010
50%
bme graduates continue their education with a phd
Diapositive précédente
Diapositive suivante